TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2301717

Group type: COMPARATOR
Intervention: Systemic clindamycin preoperatively
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Combined systemic clindamycin and topical ampicillin
Number of subjects: 246
Study: 7470203

Group type: EXPERIMENTAL
Intervention: 4 g of cholestyramine twice daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: 8 g of cholestyramine twice daily
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 16 g of cholestyramine daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: 8 g of cholestyramine daily
Number of subjects: 16
Study: 31331550

Group type: EXPERIMENTAL
Intervention: Enterokind (Chamomilla D6, Cina D6, Colocynthis D6, Lac defloratum D6, Magnesium chloratum D6)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Simethicone
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Enterokind
Number of subjects: 125
Study: 28426903

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (Btx‐A) - 50 units in 2.5 ml sterile saline
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sterile saline (placebo) - 2.5 ml
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (Btx‐A)
Number of subjects: 40
Study: 25616206

Group type: EXPERIMENTAL
Intervention: Intravenous Mg sulphate 40 mg kg(‐1) followed by an infusion of 10 mg kg(‐1) h(‐1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isotonic saline (control)
Number of subjects: 40
Study: 23348071

Group type: COMPARATOR
Intervention: First quartile of fruit intake (23 g/day)
Number of subjects: 978

Group type: EXPERIMENTAL
Intervention: Second quartile of fruit intake (mean intake not specified)
Number of subjects: 978

Group type: EXPERIMENTAL
Intervention: Third quartile of fruit intake (mean intake not specified)
Number of subjects: 978

Group type: EXPERIMENTAL
Intervention: Fourth quartile of fruit intake (mean intake not specified)
Number of subjects: 978
Study: 21550905

Group type: EXPERIMENTAL
Intervention: CoStar stent
Number of subjects: 303

Group type: COMPARATOR
Intervention: Bare metal stent
Number of subjects: 303
Study: 19147457

Group type: EXPERIMENTAL
Intervention: Pacing at 55 b.p.m.
Number of subjects: 12
Study: 17530683

Group type: EXPERIMENTAL
Intervention: Operant-behavioral therapy (OBT)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Attention placebo (AP)
Number of subjects: 125
Study: 16490090

Group type: EXPERIMENTAL
Intervention: Propofol formulated with long‐chain triglycerides (LCT)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Propofol formulated with mixed medium‐chain/long‐chain triglycerides (MCT/LCT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Both propofol formulations (LCT and MCT/LCT)
Number of subjects: 90
Study: 14658184

Group type: EXPERIMENTAL
Intervention: Oral feeding 48 to 72 hours after total laryngectomy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Oral feeding 10 to 12 days after total laryngectomy
Number of subjects: 42
Study: 10650525

Group type: EXPERIMENTAL
Intervention: picasol (n-3 polyunsaturated fatty acids)
Number of subjects: 60

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 60
Study: 8660109

Group type: EXPERIMENTAL
Intervention: Sulphasalazine desensitisation
Number of subjects: 422

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 422
Study: 1984300

Group type: EXPERIMENTAL
Intervention: Cine CT
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High-resolution CT
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combined technique (high-resolution CT for entire airway and cine CT at selected areas)
Number of subjects: 20
Study: 6410450

Group type: EXPERIMENTAL
Intervention: Ro 15‐1788 (up to 600 mg)
Number of subjects: 0
Study: 31591066

Group type: EXPERIMENTAL
Intervention: Standard case definition combining acute respiratory symptoms and signs with ancillary tests
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active hospital-based pneumonia surveillance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Longitudinal follow-up of children younger than 1 year
Number of subjects: 0
Study: 28850681

Group type: EXPERIMENTAL
Intervention: 8-mg dexamethasone every 8 hours for up to 4 days after surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26619202

Group type: EXPERIMENTAL
Intervention: Exercise during haemodialysis (30-min bout)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Resting haemodialysis
Number of subjects: 15
Study: 23871259

Group type: EXPERIMENTAL
Intervention: Oral pressure therapy (OPT)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 63
Study: 21537297

Group type: COMPARATOR
Intervention: Alginate dressing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hydrofiber dressing
Number of subjects: 0
Study: 20121985

Group type: EXPERIMENTAL
Intervention: Cardiovascular exercise training (moderate intensity, 60-70% maximal oxygen uptake)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Flexibility and balance training (control group)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Cardiovascular exercise training
Number of subjects: 144

Group type: COMPARATOR
Intervention: Flexibility and balance training
Number of subjects: 144
Study: 16940094

Group type: EXPERIMENTAL
Intervention: Amoxicillin (AMX) 2 g
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Clindamycin (CLI) 600 mg
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Moxifloxacin (MXF) 400 mg
Number of subjects: 221

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 221
Study: 15302567

Group type: EXPERIMENTAL
Intervention: Duloxetine 80 mg per day (40 mg twice daily)
Number of subjects: 0
Study: 11753267

Group type: EXPERIMENTAL
Intervention: St John's Wort (300 mg, three times a day for 14 days)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 9266538

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 supplementation (90 mg/day)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 supplementation
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 8440431

Group type: EXPERIMENTAL
Intervention: Zaldaride maleate 20 mg
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study: 3758151

Group type: EXPERIMENTAL
Intervention: Topical beclomethasone dipropionate suspension
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo suspension
Number of subjects: 14
Study: 31473111

Group type: EXPERIMENTAL
Intervention: Cefepime 1 g administered intravenously every 8 h for an average of 10.5 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Meropenem 0.5 g administered intravenously every 8 h for an average of 10.5 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cefepime and Meropenem
Number of subjects: 0
Study: 30274327

Group type: EXPERIMENTAL
Intervention: Regular coffee
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Decaffeinated coffee
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 28164344

Group type: EXPERIMENTAL
Intervention: Iron supplementation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (casual ice chewers)
Number of subjects: 22
Study: 25466880

Group type: EXPERIMENTAL
Intervention: Positive mood state
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral mood state
Number of subjects: 0
Study: 23098170

Group type: EXPERIMENTAL
Intervention: Ingesting all prescribed hypertension medications upon awakening
Number of subjects: 3344

Group type: COMPARATOR
Intervention: Ingesting the entire daily dose of ≥1 hypertension medication at bedtime
Number of subjects: 3344

Group type: EXPERIMENTAL
Intervention: Ambulatory BP thresholds for men
Number of subjects: 3344

Group type: EXPERIMENTAL
Intervention: Ambulatory BP thresholds for women
Number of subjects: 3344

Group type: EXPERIMENTAL
Intervention: Comparison of ambulatory BP and CVD risk
Number of subjects: 3344

Group type: EXPERIMENTAL
Intervention: Outcome-based reference thresholds for diagnosis of hypertension
Number of subjects: 3344
Study: 21951244

Group type: EXPERIMENTAL
Intervention: Teach to Goal intervention (multisession educational strategy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single-session brief educational intervention
Number of subjects: 0
Study: 18440754

Group type: COMPARATOR
Intervention: bThrombin
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: rThrombin
Number of subjects: 164
Study: 16569109

Group type: EXPERIMENTAL
Intervention: Written expressive disclosure
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Benefit finding
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fact-control condition
Number of subjects: 60
Study: 12654443

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (5 x 5 Gy)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Postoperative radiotherapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Surgery-only (no radiotherapy)
Number of subjects: 120
Study: 14532316

Group type: EXPERIMENTAL
Intervention: Methotrexate (15 to 20 mg/wk)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 10506633

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.75 mg qid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Megestrol acetate 800 mg orally every day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluoxymesterone 10 mg orally bid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Megestrol acetate
Number of subjects: 0
Study: 8522683

Group type: EXPERIMENTAL
Intervention: Constrictive pericarditis
Number of subjects: 30

Group type: COMPARATOR
Intervention: Restrictive cardiomyopathy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal volunteers
Number of subjects: 30
Study: 1365469

Group type: EXPERIMENTAL
Intervention: Nabumetone
Number of subjects: 42

Group type: COMPARATOR
Intervention: Indomethacin
Number of subjects: 42
Study: 6828614

Group type: EXPERIMENTAL
Intervention: Monetary Incentive
Number of subjects: 41

Group type: COMPARATOR
Intervention: Non‐incentive Control
Number of subjects: 41
Study: 28742685

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy followed by chemoradiation and surgery
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy followed by chemoradiation and surgery with cetuximab
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (no cetuximab)
Number of subjects: 82
Study: 29283254

Group type: EXPERIMENTAL
Intervention: Increased number of electron-donating groups
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Steric effects
Number of subjects: 0
Study: 26509382

Group type: EXPERIMENTAL
Intervention: Low-dose CO inhalation (1.2 mL·kg(‐1) body mass)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Room air (control)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Low-dose CO inhalation
Number of subjects: 9
Study: 24713188

Group type: EXPERIMENTAL
Intervention: recombinant Factor VIIa (rFVIIa)
Number of subjects: 497

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 497
Study: 22731245

Group type: EXPERIMENTAL
Intervention: Forskolin and rutin (2 tablets per day)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (normal topical therapy only)
Number of subjects: 97
Study: 20668826

Group type: EXPERIMENTAL
Intervention: Hyperbaric levobupivacaine 1.5 mg (perianal)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Hyperbaric levobupivacaine 6 mg (saddle)
Number of subjects: 78
Study: 16822563

Group type: EXPERIMENTAL
Intervention: Nebivolol (5 mg daily for 6 months)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Metoprolol (100 mg daily for 6 months)
Number of subjects: 80
Study: 16249527

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet for 6 weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: High-monounsaturated fat diet for 6 weeks
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet for 14 weeks (n=13)
Number of subjects: 42

Group type: COMPARATOR
Intervention: High-monounsaturated fat diet for 6 weeks (after 14 weeks of high-carb)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: High-monounsaturated fat diet for 14 weeks (n=8)
Number of subjects: 42

Group type: COMPARATOR
Intervention: High-carbohydrate diet for 6 weeks (after 14 weeks of high-mono)
Number of subjects: 42
Study: 11878059

Group type: EXPERIMENTAL
Intervention: Xenical (orlistat) 360 mg/day with diet
Number of subjects: 30

Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 30
Study: 9536565

Group type: EXPERIMENTAL
Intervention: Sumatriptan 25 mg
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Sumatriptan 12.5 mg
Number of subjects: 184

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Sumatriptan (both doses)
Number of subjects: 184
Study: 7633301

Group type: EXPERIMENTAL
Intervention: Subcutaneous administration of apomorphine (0.005 mg/kg) in heroin addicts
Number of subjects: 2

Group type: COMPARATOR
Intervention: Subcutaneous administration of apomorphine (0.005 mg/kg) in healthy volunteers
Number of subjects: 2
Study: 2673693

Group type: EXPERIMENTAL
Intervention: Miglitol (300 mg/day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 363236

Group type: EXPERIMENTAL
Intervention: Linoleic acid (20 g)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Naudicelle (linoleic acid with gamma-linolenic acid)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Oleic acid (as a spread)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Oleic acid (in capsules)
Number of subjects: 116
Study: 29601904

Group type: EXPERIMENTAL
Intervention: Methyl aminolevulinate (MAL) incubation without prior curettage (‐Cur)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Methyl aminolevulinate (MAL) incubation after curettage (+Cur)
Number of subjects: 14
Study: 28177953

Group type: COMPARATOR
Intervention: Citalopram 40 mg/day
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Vilazodone 40 mg/day
Number of subjects: 79
Study: 26368268

Group type: EXPERIMENTAL
Intervention: Kirschner wire
Number of subjects: 46

Group type: COMPARATOR
Intervention: Nerve root retractor
Number of subjects: 46
Study: 23764721

Group type: EXPERIMENTAL
Intervention: Optimized T1-MPRAGE sequence
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard STIR sequence
Number of subjects: 40
Study: 21561703

Group type: EXPERIMENTAL
Intervention: Concomitant posterior intravaginal slingplasty (IVS)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Concomitant sacrospinous ligament fixation (SSLF)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Both IVS and SSLF
Number of subjects: 22
Study: 18296554

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 148
Study: 16931673

Group type: EXPERIMENTAL
Intervention: Lower BIS regimen (median BIS, 38.9)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Higher BIS regimen (mean BIS, 50.7)
Number of subjects: 74
Study: 12947434

Group type: EXPERIMENTAL
Intervention: Glycaemic glucose equivalent (GGE) doses of 10 and 20 GGE for yams, biscuits, white rice, and porridge; 24 and 48 GGE for 2-minute noodles
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: GGE intake
Number of subjects: 24
Study: 11719144

Group type: EXPERIMENTAL
Intervention: CPR with audio feedback from the manikin
Number of subjects: 24

Group type: COMPARATOR
Intervention: CPR without feedback
Number of subjects: 24
Study: 9225069

Group type: EXPERIMENTAL
Intervention: Granulocyte colony‐stimulating factor (G‐CSF) and erythropoietin (EPO)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Patients with MDS
Number of subjects: 51

Group type: COMPARATOR
Intervention: Patients with RAS
Number of subjects: 51

Group type: COMPARATOR
Intervention: Patients with RAEB
Number of subjects: 51
Study: 7954488

Group type: EXPERIMENTAL
Intervention: Moclobemide 200 mg b.i.d.
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Brofaromine 75 mg b.i.d.
Number of subjects: 34

Group type: COMPARATOR
Intervention: Mianserin 10 mg t.i.d.
Number of subjects: 34

Group type: COMPARATOR
Intervention: Doxepin 25 mg t.i.d.
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Brofaromine (both doses)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Moclobemide
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both drugs (Moclobemide and Brofaromine)
Number of subjects: 34
Study: 3302005

Group type: EXPERIMENTAL
Intervention: Pirenzepine 50 mg twice daily
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 2359974

Group type: EXPERIMENTAL
Intervention: Viscous bolus (syrup; viscosity, 102 centipoise) at varying volumes (5, 10, 15, 20 ml)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-viscous bolus (water; viscosity, 0.89 centipoise) at varying volumes (5, 10, 15, 20 ml)
Number of subjects: 0
Study: 1228216

Group type: EXPERIMENTAL
Intervention: Oxytocin (5-10 and 15 mulli-units per minute)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Prostaglandin F2 alpha (12.5-25 and 37.5 microgrammes per minute)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Oxytocin or Prostaglandin F2 alpha
Number of subjects: 50
Study: 31848703

Group type: EXPERIMENTAL
Intervention: RT + BFR
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: RT
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study: 31473510

Group type: EXPERIMENTAL
Intervention: High-fat meal supplemented with blueberry powder
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: High-fat meal supplemented with docosahexaenoic acid (DHA)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: High-fat meal supplemented with placebo
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Universal postprandial response
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Subject-specific postprandial responses
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Monitoring gene expression at multiple time points
Number of subjects: 5
Study: 27856150

Group type: EXPERIMENTAL
Intervention: Auto-fluorescence guided bone surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Tetracycline fluorescence guided bone surgery
Number of subjects: 40
Study: 25887849

Group type: EXPERIMENTAL
Intervention: Intervention package including use of a new continuum of care card, orientation for health workers, 24-hour health facility retention, and postnatal care by home visits.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention package
Number of subjects: 0
Study: 23584162

Group type: EXPERIMENTAL
Intervention: Transforaminal lumbar interbody fusion (TLIF)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Posterolateral instrumented fusion (PLF)
Number of subjects: 100
Study: 22044568

Group type: EXPERIMENTAL
Intervention: Relationship-based intervention
Number of subjects: 15

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 15
Study: 19683927

Group type: COMPARATOR
Intervention: Conventional radiofrequency (CRF)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Trigeminal peripheral division radiofrequency thermocoagulation (PRT)
Number of subjects: 50
Study: 17851860

Group type: EXPERIMENTAL
Intervention: Leucocyte-depleted red blood cells (LDB)
Number of subjects: 642

Group type: COMPARATOR
Intervention: Packed red blood cells (RBC)
Number of subjects: 642

Group type: COMPARATOR
Intervention: Non-transfused patients
Number of subjects: 642
Study: 12556685

Group type: EXPERIMENTAL
Intervention: 2% PRO 2000 Gel, once or twice daily for 14 days
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 4% PRO 2000 Gel, twice daily for 14 days
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 63
Study: 10642968

Group type: EXPERIMENTAL
Intervention: Acoustic Stimulation Test (AST)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Nonstress Test (NST)
Number of subjects: 400
Study: 8546555

Group type: COMPARATOR
Intervention: Influenza vaccine alone
Number of subjects: 9336

Group type: EXPERIMENTAL
Intervention: Influenza and pneumococcal vaccines
Number of subjects: 9336
Study: 2064515

Group type: EXPERIMENTAL
Intervention: Vitamin-K antagonists and dipyridamole
Number of subjects: 469

Group type: COMPARATOR
Intervention: Vitamin-K antagonists and placebo
Number of subjects: 469
Study: 6342785

Group type: EXPERIMENTAL
Intervention: Cyclacillin, administered three times a day for ten days
Number of subjects: 134

Group type: COMPARATOR
Intervention: Amoxicillin, administered similarly
Number of subjects: 134
Study: 30916714

Group type: EXPERIMENTAL
Intervention: Sodium Nitroprusside (SNP)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 28497480

Group type: EXPERIMENTAL
Intervention: p‐EVES (portable electronic vision enhancement systems)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Optical aids only
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: p‐EVES
Number of subjects: 100
Study: 27245042

Group type: EXPERIMENTAL
Intervention: Jingui Shenqi pill combined with nifedipine sustained-release tablets
Number of subjects: 96

Group type: COMPARATOR
Intervention: Nifedipine sustained-release tablets
Number of subjects: 96
Study: 24179979

Group type: EXPERIMENTAL
Intervention: Argon plasma cleaning/sterilisation
Number of subjects: 20

Group type: COMPARATOR
Intervention: 5-second steam cleaning
Number of subjects: 20
Study: 21253001

Group type: EXPERIMENTAL
Intervention: In-person condition
Number of subjects: 323

Group type: COMPARATOR
Intervention: Internet condition
Number of subjects: 323
Study: 19388835

Group type: EXPERIMENTAL
Intervention: Delayed primary closure (DPC)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Primary closure (PC)
Number of subjects: 77
Study: 16715189

Group type: EXPERIMENTAL
Intervention: 25 mg/kg methylprednisolone (Group I)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline (Group II)
Number of subjects: 40
Study: 15278206

Group type: EXPERIMENTAL
Intervention: Matrix‐guided autologous chondrocyte implantation (MACI)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Microfracture (MFX)
Number of subjects: 27
Study: 10865157

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 235

Group type: COMPARATOR
Intervention: Structured exercise intervention
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 235
Study: 9105094

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (4 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (10 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 1435827

Group type: EXPERIMENTAL
Intervention: Low-phosphate cow's milk
Number of subjects: 31

Group type: COMPARATOR
Intervention: Conventional cow's milk
Number of subjects: 31